Brolucizumab Intravitreal Injections for Wet Age-Related Macular Degeneration: Real-Life Study on a Cohort of Italian Patients

Brolucizumab Intravitreal Injections for Wet Age-Related Macular Degeneration: Real-Life Study on a Cohort of Italian Patients

<i>Background and Objectives:</i> To report the real-life Brolucizumab therapeutical outcomes of treatment-naïve and non-treatment-naïve eyes with neovascular age-related macular degeneration (nAMD) and to analyze the incidence of therapy-related adverse events. <i>Materials and Me...

Full description

Bibliographic Details
Main Authors: Carlo Gesualdo, Settimio Rossi, Clemente Maria Iodice, Francesco Guarino, Mariachiara Petrella, Fabiana Anna D’Agostino, Raffaele Perrotta, Francesca Simonelli
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Medicina
Subjects:
age-related macular degeneration
anti-vascular endothelial growth factor
brolucizumab
central retinal thickness
exudation
intravitreal injection
Online Access:https://www.mdpi.com/1648-9144/59/6/1110

Internet

https://www.mdpi.com/1648-9144/59/6/1110

Similar Items